Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
申请人:——
公开号:US20030229072A1
公开(公告)日:2003-12-11
Disclosed are cyclic and acyclic amidines, pharmaceutical compositions containing such amidines, and their use in treating or preventing progesterone receptor mediated diseases or conditions, such as osteopenia and osteoporosis.
CYCLIC AND ACYCLIC AMIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS
申请人:Bayer Corporation
公开号:EP1317456A2
公开(公告)日:2003-06-11
[EN] CYCLIC AND ACYCLIC AMIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS<br/>[FR] AMIDINES CYCLIQUES ET ACYCLIQUES ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES UTILISES COMME AGENTS DE LIAISON DE RECEPTEUR DE PROGESTERONE
申请人:BAYER AG
公开号:WO2002020526A2
公开(公告)日:2002-03-14
Disclosed are cyclic and acyclic amidines, pharmaceutical compositions containing such amidines, and their use in treating or preventing progesterone receptor mediated diseases or conditions, such as osteopenia and osteoporosis.
Notes - Synthesis of Spirolactams from Nitrocycloalkanes
作者:R. Hill
DOI:10.1021/jo01358a606
日期:1957.7
[EN] STAT DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION DE STAT ET LEURS UTILISATIONS
申请人:KYMERA THERAPEUTICS INC
公开号:WO2021188696A1
公开(公告)日:2021-09-23
The present invention provides compounds, compositions thereof, and methods of using the same.